Stockholm, Sweden – 5th of June 2024.

Today, Voima Ventures, announced several key appointments. These include a new female Partner in Sweden and additional team and board members. These initiatives demonstrate Voima Ventures’ commitment to better health, cleaner industry practices, diversity, and environmental sustainability, aligning with their Fund III investment thesis.

Jenny Engerfelt, the new Partner, joined Voima Ventures as an Investment Director two years ago from Almi Invest, bringing over a decade of early-stage VC experience. Along with Venture Advisor Malin Carlstrom, she has built a strong foundation for Voima Ventures’ Nordic operations, extending across the technology ecosystem, local universities, and investors. Voima Ventures’ latest investment was into a Swedish biopharma company ArgusEye, also led by Jenny Engerfelt.

She expressed her enthusiasm, saying, “It’s an honour to step into the role of Partner at Voima Ventures. Over the past years and with the launch of Voima Ventures Fund III our team has built a formidable foundation. Now, we are excellently positioned to magnify our impact and invest in scaling the companies that can really move the needle on important global challenges that only science can solve.”

Picture: Voima Ventures Fund III (now 100M€, with final close in October) Partners: Jussi Sainiemi, Jenny Engerfelt, Inka Mero and Pontus Stråhlman.

Additionally, Anders Nordström has been appointed to the Swedish Board of Directors. Anders has held several executive positions in global life science companies and invested in early-stage ventures. His expertise and investment track record will be invaluable as Voima Ventures aims to support the Swedish life science ecosystem and expand its network.

Voima Ventures is actively recruiting a Life Sciences Investment Professional to capitalise on growing opportunities. This role will navigate the expansive network of research institutes and universities, analyse emerging companies, and implement their life sciences investment strategy.

The firm also announced the promotion of Anna Pölönen to Analyst, following her exceptional year as a Junior Analyst. This advancement highlights Voima Ventures’ commitment to nurturing internal talent and fostering professional growth.

These steps reinforce the firm’s plan to strengthen its impact in Sweden and beyond, driving forward its mission to invest in ventures that contribute positively to society and the environment.
Picture: Team advancement in Voima Ventures; Anna Pölönen (Analyst), Jenny Engerfelt (Partner), Anders Nordström (BoD member)

Inka Mero, Founder and Managing Partner, commented: “Since our foundation, we have set the path for Voima Ventures not only as a leader in deep tech VC investing with high returns but also in promoting diversity. Building diversity in the venture capital and technology ecosystem requires systematic work, and I am extremely proud to have both Jenny Engerfelt and Anna Pölönen in our exceptional team.”

She continued, “We also warmly welcome Anders Nordström to our Swedish Board, enhancing our life sciences expertise for the next growth phase. The importance of Sweden will continue to grow in our investment focus. Jenny’s excellent work in cultivating our local presence in the ecosystem has been invaluable, and her new role as Partner will further strengthen our mission for the years to come. These steps, along with our Fund III goal of 25-30 investments across the science startup ecosystem in the Nordics and Baltics, position us to drive meaningful advancements while creating lasting value in the region.’

Anders Nordström commented, “Joining Voima Ventures board is a unique opportunity to contribute to a vision that aligns with my commitment to advancing life sciences. Together, we will catalyse significant advancements in health and environmental sustainability.”